MET(MET)
MET
Q3 2026 EPS Estimate
$2.39
Aug 5, 2026 · Reports after close
Revenue Estimate
$19.68B
FY2026E EPS$9.93
FY2027E EPS$10.99
Analyst Sentiment
Wall St. Consensus
Buy23 analysts·High coverage
70
Score
18 Buy (78%)5 Hold (22%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1878%
Hold
522%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$90.00
+4.7%
Consensus
$95.00
+10.5%
Bull
$102.00
+18.7%
12-Month Target Range23 analysts
$90.00$95.00$102.00
Current $85.95Consensus
Current Price
$85.95
Upside to Consensus
$9.05
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+4.25%
EPS+10.74%
FY2028
Rev+4.59%
EPS+11.45%
FY2029
Rev+5.65%
EPS+10.20%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $80.63B | $84.05B | $87.92B | $92.89B |
| Low | $79.03B | $81.38B | $87.56B | $90.66B |
| High | $82.22B | $85.92B | $88.28B | $94.65B |
| EBITDA Avg | $8.46B | $8.82B | $9.22B | $9.75B |
| Low | $8.29B | $8.54B | $9.19B | $9.51B |
| High | $8.63B | $9.02B | $9.26B | $9.93B |
| EBIT Avg | $7.63B | $7.95B | $8.32B | $8.79B |
| Low | $7.48B | $7.70B | $8.29B | $8.58B |
| High | $7.78B | $8.13B | $8.35B | $8.96B |
| Net Income Avg | $6.70B | $7.39B | $7.83B | $8.98B |
| Low | $6.41B | $7.12B | $6.84B | $8.70B |
| High | $6.98B | $7.65B | $8.82B | $9.20B |
| EPS Avg | $9.93 | $10.99 | $12.25 | $13.50 |
| Low | $9.65 | $10.71 | $10.29 | $13.08 |
| High | $10.49 | $11.50 | $13.27 | $13.83 |
| Analysts (Rev / EPS) | 7 / 11 | 7 / 11 | 6 / 6 | 5 / 4 |
Quarterly
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $19.83B | $20.19B | $20.70B | $20.56B | $20.91B | $21.07B | $21.69B | $21.87B |
| Low | $19.03B | $18.77B | $19.89B | $19.76B | $20.10B | $20.25B | $20.85B | $21.02B |
| High | $20.42B | $21.30B | $21.34B | $21.20B | $21.56B | $21.72B | $22.36B | $22.54B |
| EBITDA Avg | $2.08B | $2.12B | $2.17B | $2.16B | $2.19B | $2.21B | $2.28B | $2.29B |
| Low | $2.00B | $1.97B | $2.09B | $2.07B | $2.11B | $2.12B | $2.19B | $2.21B |
| High | $2.14B | $2.23B | $2.24B | $2.22B | $2.26B | $2.28B | $2.35B | $2.37B |
| EBIT Avg | $1.88B | $1.91B | $1.96B | $1.95B | $1.98B | $1.99B | $2.05B | $2.07B |
| Low | $1.80B | $1.78B | $1.88B | $1.87B | $1.90B | $1.92B | $1.97B | $1.99B |
| High | $1.93B | $2.02B | $2.02B | $2.01B | $2.04B | $2.06B | $2.12B | $2.13B |
| Net Income Avg | $1.57B | $1.67B | $1.69B | $1.63B | $1.81B | $1.86B | $1.89B | $1.77B |
| Low | $1.50B | $1.59B | $1.61B | $1.54B | $1.72B | $1.76B | $1.79B | $1.68B |
| High | $1.69B | $1.75B | $1.76B | $1.69B | $1.89B | $1.93B | $1.96B | $1.84B |
| EPS Avg | $2.39 | $2.54 | $2.58 | $2.48 | $2.77 | $2.83 | $2.88 | $2.70 |
| Low | $2.28 | $2.42 | $2.45 | $2.36 | $2.63 | $2.69 | $2.74 | $2.57 |
| High | $2.57 | $2.67 | $2.68 | $2.58 | $2.88 | $2.95 | $3.00 | $2.81 |
| Analysts (Rev / EPS) | 5 / 10 | 5 / 10 | 2 / 4 | 2 / 4 | 2 / 4 | 2 / 4 | 2 / 4 | 1 / 5 |